Salvat Laboratories announces submission of New Drug Application to the U.S. FDA for Clobetasol Nanoemulsion for treating inflammation and pain after ocular surgery
- Details
- Category: Business
![Salvat Laboratories Salvat Laboratories](/images/logo/salvat.png)
This submission comes after two successful phase III clinical trials conducted between 2020 and 2021.
Pfizer and BioNTech receive positive CHMP opinion for Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster in European Union
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
BioNTech's statement on patent infringement lawsuit filed by Moderna
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
Moderna sues Pfizer and BioNTech for infringing patents central to Modernas innovative mRNA technology platform
- Details
- Category: Business
![Moderna, Inc. Moderna, Inc.](/images/logo/moderna.png)
Positive Phase 1 data from mRNA-based individualized neoantigen specific immunotherapy in patients with resected pancreatic cancer
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
Nearly 700,000 US hospitalizations and 110,000 deaths prevented from the Pfizer-BioNTech COVID-19 vaccine
- Details
- Category: Business
The profound health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in detail in a new study in the peer-reviewed Journal of Medical Economics.
It is estimated that in 2021 the vaccine, the most widely used against COVID-19 in the US, prevented 8.7 million symptomatic cases of the virus, as well as 690,000 hospitalizations and more than 110,000 deaths.
Pfizer and BioNTech provide update on COVID-19 vaccine supply agreement with European Commission
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
More Pharma News ...
- Pfizer and BioNTech receive expanded U.S. emergency use authorization for an additional COVID-19 vaccine booster in individuals aged 50 years and older
- Statement on humanitarian aid in Ukraine
- BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
- BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
- Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine
- Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine
- European Commission grants conditional marketing authorization for Novavax COVID-19 vaccine